In conclusion, there is cumulative evidence suggesting that, besides the hypo-uricemic effect, long-term treatment with Xanthine Oxidase inhibitors may bring reno-protective benefits in individuals with non-advanced chronic kidney disease. This evidence concerns the gene XDH and chronic kidney disease.